James B. Leverenz
- Neurology top 0.05%
- Parkinson's Disease Mechanisms and Treatments 72
- Neuroinflammation and Neurodegeneration Mechanisms 24
- Neurological disorders and treatments 23
- Neurology top 0.1%
- Parkinson's Disease Mechanisms and Treatments 72
- Neuroinflammation and Neurodegeneration Mechanisms 24
- Neurological disorders and treatments 23
- Physiology top 0.1%
- Alzheimer's disease research and treatments 99
- Biological Psychiatry top 0.5%
- Psychiatry and Mental health top 0.2%
- Dementia and Cognitive Impairment Research 80
-
- Ginkgo biloba and Cashew Applications 16
-
- Neuroscience and Neuropharmacology Research 15
-
- Cholinesterase and Neurodegenerative Diseases 15
- Co-authors
- Thomas J. MontineElaine R. PeskindMurray A. RaskindCyrus P. ZabetianPamela J. McMillanDebby W. TsuangJoseph F. QuinnLynn M. Bekris
- Cited by
- NeurologyPhysiology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)The Journal of Experimental Medicine (1 paper)Journal of Neuroscience (2 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
James B. Leverenz
246 papers receiving 14.4k citations
Hit Papers
Peers
Comparison fields: 5 of 171
- Neurology 6.1k
- Neurology 3.0k
- Physiology 6.2k
- Biological Psychiatry 497
- Psychiatry and Mental health 2.9k
Countries citing papers authored by James B. Leverenz
This map shows the geographic impact of James B. Leverenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James B. Leverenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James B. Leverenz more than expected).
Fields of papers citing papers by James B. Leverenz
This network shows the impact of papers produced by James B. Leverenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James B. Leverenz. The network helps show where James B. Leverenz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James B. Leverenz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 42 | |
| 4 | 2021 | 56 | |
| 5 | 2021 | 12 | |
| 6 | 2020 | 18 | |
| 7 | 2020 | 27 | |
| 8 | 2019 | 32 | |
| 9 | 2019 | 8 | |
| 10 | 2018 | 18 | |
| 11 | 2012 | 85 | |
| 12 | 2011 | 96 | |
| 13 | 2009 | 38 | |
| 14 | 2007 | 204 | |
| 15 | 2007 | 96 | |
| 16 | 2005 | 28 | |
| 17 | 2005 | 5 | |
| 18 | Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues. | 2001 | 131 |
| 19 | 1999 | 131 | |
| 20 | 1997 | 3 |
About James B. Leverenz
James B. Leverenz is a scholar working on Neurology, Psychiatry and Mental health and Neurology, having authored 253 papers that have together received 14.7k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (99 papers), Dementia and Cognitive Impairment Research (80 papers), Parkinson's Disease Mechanisms and Treatments (72 papers), Neuroinflammation and Neurodegeneration Mechanisms (24 papers), Neurological disorders and treatments (23 papers), Ginkgo biloba and Cashew Applications (16 papers), Neuroscience and Neuropharmacology Research (15 papers) and Cholinesterase and Neurodegenerative Diseases (15 papers). The work is most often cited by research in Neurology (6.1k citations), Neurology (3.0k citations) and Physiology (6.2k citations). James B. Leverenz has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Thomas J. Montine, Elaine R. Peskind, Murray A. Raskind, Cyrus P. Zabetian, Pamela J. McMillan, Debby W. Tsuang, Joseph F. Quinn, Lynn M. Bekris, Suzanne Craft and Gerard D. Schellenberg. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.